Healthcare Sales & Marketing Network News: Migraine

Searching News Database: Migraine

HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 26 Sep 2023
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 17 Aug 2023
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 21 Apr 2023
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA(R)) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Dec 2022
Neurolief Appoints Neuromodulation Industry Leader Scott Drees as CEO
Devices Neurology Personnel

HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2021
Biohaven Names CEO Vlad Coric, MD, Chairman Of The Board Of Directors And Matthew Buten, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Nov 2021
NURTEC(R) ODT Approved In Kuwait For Acute Treatment Of Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Nov 2021
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 Jun 2021
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 25 Jan 2021
FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
Devices Neurology FDA

HSMN NewsFeed - 19 Jan 2021
Theranica Adds Digital Therapeutics Expert Donald Jones to its Board of Directors
Devices Personnel

HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Nov 2020
Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution
Devices Neurology FDA

HSMN NewsFeed - 9 Oct 2020
Lilly's OVERCOME Study Reveals Nearly 80% of People Reported Improvement in Their Migraine Since Starting a CGRP Monoclonal Antibody for Preventive Treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Oct 2020
REYVOW(R) (lasmiditan) C-V Demonstrated Superior Pain Freedom At 2 Hours in At Least 2 of 3 Migraine Attacks in New Phase 3 Consistency of Effect Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 11 Sep 2020
REYVOW(TM) (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Jun 2020
Biohaven Appoints Bob Hugin to its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 26 May 2020
Emgality(R) Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 May 2020
Cipla Receives Final Approval for Generic Version of Migranal(R) (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 19 May 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for Migraine
Biopharmaceuticals Distribution

HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 23 Mar 2020
Biohaven to Advance Vazegepant into Phase 3 for the Acute Treatment of Migraine Following Successful End of Phase 2 Meeting with FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2019
Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality(R) (galcanezumab-gnlm)
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Dec 2019
Prasco launches NuvaRing(R) (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
Biopharmaceuticals Generics Drug Delivery Product Launch

HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch

HSMN NewsFeed - 5 Aug 2019
Lilly Announces Positive Results for Emgality(R) (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Jul 2019
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Jul 2019
AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality(R) (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jul 2019
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality(R) (galcanezumab-gnlm) in Episodic Cluster Headache
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Jun 2019
Theranica Appoints Senior Executives to Lead its New USA Subsidiary
Devices Neurology Personnel

HSMN NewsFeed - 28 May 2019
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
Devices Neurology FDA

HSMN NewsFeed - 13 May 2019
OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
Devices Neurology Venture Capital

HSMN NewsFeed - 24 Apr 2019
Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Feb 2019
eNeura, Inc. Receives FDA Clearance for Acute Treatment and Prevention of Migraine in Children 12 Years of Age and Older
Devices Neurology FDA

HSMN NewsFeed - 2 Jan 2019
Slayback Pharma Announces FDA Approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml in a Multi-Dose Vial, the First Generic Equivalent of Makena(R) Injection 1,250 mg/ 5 ml Multi-Dose Vial
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Sep 2018
Lilly Receives Positive CHMP Opinion for Emgality(TM) (galcanezumab) for the Prophylaxis of Migraine in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 17 Sep 2018
Anti-migraine Head Patch - HeadaTerm - Receives FDA Clearance
Devices Neurology FDA

HSMN NewsFeed - 12 Sep 2018
Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 17 Aug 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Devices Neurology FDA

HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2018
NobleStitch(TM) EL PFO Closure Highlighted at CSI Congress with Prof. Horst Sievert Performing his 100th NobleStitch Case on Opening Day
Devices Interventional Cardiology

HSMN NewsFeed - 3 Jul 2018
Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Biopharmaceuticals Oncology Drug Delivery Acquisitions

HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 11 Jun 2018
Propeller Health Raises Strategic Investment from McKesson Ventures
Devices Venture Capital

HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing

HSMN NewsFeed - 29 May 2018
TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2018
Nobles Medical Technologies II Showcases Noblestitch(TM) PFO Closure At EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2018
EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared
Devices Neurology Product Launch

HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 15 May 2018
Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2018
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Feb 2018
eNeura, Inc. Announces Series D Financing
Devices Neurology Venture Capital

HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA

HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Nov 2017
FDA-Approved Cefaly(R) Device to Stop Migraines Now Available
Devices Neurology FDA Product Launch

HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital

HSMN NewsFeed - 20 Nov 2017
HeartStitch(R) "Sutures The Future" at the TCT in Denver, Colorado
Devices Cardiology

HSMN NewsFeed - 16 Nov 2017
Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Sep 2017
FDA Releases Cefaly(R) for Acute Treatment of Migraine Attacks
Devices Neurology FDA

HSMN NewsFeed - 11 Sep 2017
electroCore Announces Results from gammaCore(R) (non-invasive vagus nerve stimulator) Study in Migraine at the 18th Congress of the International Headache Society
Devices Neurology

HSMN NewsFeed - 8 Sep 2017
IHC 2017: Lilly's Galcanezumab Demonstrates Positive Long-Term Safety Results for up to 12 Months in Patients with Migraine
Biopharmaceutical Neurology

HSMN NewsFeed - 7 Sep 2017
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
Devices Neurology FDA

HSMN NewsFeed - 4 Aug 2017
Lilly Announces Positive Results for Second Phase 3 Study of Lasmiditan for the Acute Treatment of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Aug 2017
Biohaven Appoints Julia P. Gregory to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 31 Jul 2017
Biohaven Initiates Second Pivotal Phase 3 Clinical Trial of Oral CGRP Antagonist for the Acute Treatment of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jul 2017
Theranica Raises $6M to Combat Migraine
Devices Neurology Venture Capital

HSMN NewsFeed - 18 May 2017
Amgen Submits Biologics License Application To The FDA For Erenumab
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 May 2017
Alcobra Announces Leadership Update
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2017
Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA

HSMN NewsFeed - 17 Apr 2017
AMAG Submits Supplemental New Drug Application to FDA for Makena(R) (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 6 Apr 2017
Supernus Receives Final FDA Approval for Trokendi XR(R) for Migraine Prophylaxis in Adults and Adolescents
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Mar 2017
Lilly Completes Acquisition of CoLucid Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine

HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals

HSMN NewsFeed - 8 Sep 2016
Zosano Appoints Georgia Erbez as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Jun 2016
HeartStitch(R) Expanding Products' Clinical Databases Across the Globe
Devices Cardiology

HSMN NewsFeed - 10 Jun 2016
HeartStitch(R) Announces Top New Sales and Marketing VP Joins the HeartStitch Team
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 25 May 2016
HeartStitch(R) Announces New Director of Regulatory Affairs and Quality Assurance
Devices Cardiology Personnel

HSMN NewsFeed - 12 May 2016
Mylan Launches Generic Frova(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 21 Apr 2016
eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention
Devices Neurology Regulatory

HSMN NewsFeed - 4 Apr 2016
ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 1 Apr 2016
NICE Provides Positive Guidance on electroCore's gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
Devices Neurology Regulatory

HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2016
Antares Pharma Announces CEO Transition
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 6 Jan 2016
Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2015
Mylan Launches Generic AXERT(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 9 Nov 2015
RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT(TM) (RHB-103) for Migraines
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 6 Oct 2015
OptiNose Closes New Round of Financing
Devices Drug Delivery Venture Capital

HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Aug 2015
Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 4 Aug 2015
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 14 Jul 2015
Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2015
Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch

HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 31 Mar 2015
Orthofix International Secures Option to Acquire eNeura, Inc.
Devices Neurology Mergers & Acquisitions

HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 26 Jun 2014
Sham Controlled Pilot Study Shows electroCore’s Non Invasive Vagus Nerve Stimulation Therapy for the Prevention of Migraine is Safe and Reduces the Number of Headache Days
Devices Neurology

HSMN NewsFeed - 10 Jun 2014
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2014
eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device
Devices Neurology FDA

HSMN NewsFeed - 14 May 2014
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 8 May 2014
Charleston Laboratories, Inc., Bolsters Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 2 Apr 2014
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Devices Regulatory

HSMN NewsFeed - 13 Mar 2014
Dolphin Neurostim Receives CE Approval for European Distribution
Devices Neurology Regulatory

HSMN NewsFeed - 27 Jan 2014
eNeura Files 510(k) with the FDA for SpringTMS(R) Migraine Treatment
Devices Neurology FDA

HSMN NewsFeed - 21 Jan 2014
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2014
Alcobra Strengthens Management Team With Addition of Industry Veteran David C. Baker as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 Jan 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Jan 2014
Mallinckrodt Pharmaceuticals and Zogenix to End Co-Promotion Agreement
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2013
Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Devices Monitoring Cardiology Regulatory

HSMN NewsFeed - 30 Sep 2013
Cimzia(R) (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Devices Neurology Personnel

HSMN NewsFeed - 14 Aug 2013
SAGE Therapeutics Appoints Biotech Industry Veteran Dr. Jeffrey Jonas to Chief Executive Officer; Expands Leadership Team with Two Key Appointments
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 19 Jul 2013
Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine
Devices Neurology

HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Mar 2013
FDA Approves New Drug Application (NDA) for Teva’s Quartette(TM) (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Mar 2013
Revance Therapeutics Announces Appointment of Lauren Silvernail as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2013
Labrys Biologics Announces Key Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2013
ATI Neurostimulation System(TM) Shown to be Highly Effective in Treating Cluster Headache – Results of a Multi-Centre European Study
Devices Neurology

HSMN NewsFeed - 23 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 26 Nov 2012
Zogenix Appoints New Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Nov 2012
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Oct 2012
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
Devices Surgery

HSMN NewsFeed - 22 Oct 2012
Dr Roger M. Perlmutter Joins Heptares' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2012
Neuros Medical Adds Vice President of Clinical and Regulatory Affairs to Management Team
Devices Neurology Personnel

HSMN NewsFeed - 3 Oct 2012
St. Jude Medical's Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients
Devices

HSMN NewsFeed - 20 Sep 2012
St. Jude Medical Receives European CE Mark Approval of Eon Mini Neurostimulator, the World’s Smallest Rechargeable Device to Treat Chronic Migraine
Devices Neurology Regulatory

HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jun 2012
Kedem Pharmaceuticals to Appoint New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Apr 2012
SeptRx(R) completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx Intrapocket PFO Occluder (IPO)
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 20 Jan 2012
NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 3 Jan 2012
SeptRx(R) reports first 20 patients have been enrolled in its “InterSEPT” CE Mark trial of the SeptRx(R) Intrapocket PFO Occluder (IPO)
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 8 Nov 2011
Nautilus Neurosciences Appoints Peter Lankau as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Oct 2011
Occlutech Wins Patent Ruling Against St Jude-AGA Medical in Italy
Devices Interventional Cardiology Litigation

HSMN NewsFeed - 26 Sep 2011
Occlutech CEO Wins Patent Lawsuit by St Jude-AGA Medical
Devices Cardiology Litigation Personnel

HSMN NewsFeed - 7 Sep 2011
St. Jude Medical Announces European Regulatory Approval of First Implanted Neurostimulation Device to Treat Chronic Migraine
Devices Regulatory

HSMN NewsFeed - 9 Aug 2011
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jul 2011
Dennis M. Flannelly Joins Phadia as Head of U.S. Marketing and Strategy
Diagnostics Personnel

HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA

HSMN NewsFeed - 11 Jul 2011
St. Jude Medical Receives FDA Approval for Expansion of BROADEN Deep Brain Stimulation Study for Depression
Devices Neurology

HSMN NewsFeed - 23 Jun 2011
St. Jude Medical Reveals Randomized Clinical Trial Data Demonstrating Benefit of Neuromodulation for Chronic Migraine
Devices Neurology

HSMN NewsFeed - 10 Jun 2011
Revance Announces $45 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Jun 2011
NovaDel Announces Changes in Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2011
St. Jude Medical Announces Australian Market Launch for First-of-Its-Kind Neurostimulation Lead Delivery System for Chronic Pain
Devices

HSMN NewsFeed - 15 Apr 2011
Preliminary Injunction Ordered in POZEN Treximet Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Feb 2011
MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 6 Jan 2011
Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Oct 2010
St. Jude Medical and AGA Medical Announce Definitive Agreement
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 26 Aug 2010
NMT Medical Announces Changes in Management and Board of Directors
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 2 Aug 2010
Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 12 Jul 2010
Neuros Medical Adds Neurostimulation Industry Veteran to Board of Directors
Devices Neurology Personnel

HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jul 2010
MonoSol Rx Announces FDA Approval of Zuplenz(R) Oral Soluble Film for Treatment of Nausea and Vomiting
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 9 Jun 2010
NovaDel Pharma Inc. Announces Appointment of Craig Johnson as Senior Vice President, Chief Financial Officer and Secretary
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 May 2010
St. Jude Medical Announces European Approval for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices Neurosurgery

HSMN NewsFeed - 19 May 2010
NMT Medical Appoints Paul H. Kramer, MD, to Board of Directors
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
Biopharmaceuticals

HSMN NewsFeed - 10 May 2010
Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA

HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2010
XenoPort Restructures to Focus on Key Programs
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2010
NMT Medical Appoints John E. Ahern to Board of Directors
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Jan 2010
MAP Pharmaceuticals Announces FDA will not Require a Second Pivotal Efficacy Study for LEVADEX(TM) NDA Submission
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 8 Jan 2010
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 1 Dec 2009
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Nov 2009
Neuros Medical Expands Management Team, Forms Advisory Board
Devices Neurology Personnel

HSMN NewsFeed - 22 Oct 2009
Zogenix and Astellas Announce Data Published Showing the Benefits of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 22 Sep 2009
Coherex Medical Signs Exclusive Distribution Agreement with Abbott
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2009
Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Aug 2009
XenoPort Appoints Dennis Fenton to Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Aug 2009
Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
Biopharmaceuticals

HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jul 2009
Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 9 Jul 2009
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Biopharmaceuticals

HSMN NewsFeed - 8 Jul 2009
Coherex Medical's Coherex FlatStent EF PFO Closure System Granted CE Mark Clearance for Closing PFOs - a Common Heart Defect; Company to Begin Sales/Marketing Efforts in Europe
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 24 Jun 2009
NMT Medical Appoints Chief Operating Officer Richard E. Davis to Board of Directors
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 26 May 2009
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 13 May 2009
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 May 2009
Occlutech Obtains CE Mark for the new Generation PFO & ASD Occluders
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2009
TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
Biopharmaceuticals

HSMN NewsFeed - 14 Apr 2009
NMT Medical Appoints Frank Martin Permanent President & CEO
Devices Cardiology Personnel

HSMN NewsFeed - 13 Apr 2009
XenoPort Announces Election of Co-Promotion Option for Solzira
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2009
NMT Medical Receives PMA Approval for STARFlex as a Ventricular Septal Defect Repair Implant
Devices Interventional Cardiology FDA

HSMN NewsFeed - 23 Mar 2009
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Mar 2009
Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
Devices Interventional Litigation

HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Feb 2009
MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 10 Feb 2009
Teva Announces Approval and Launch of Generic Imitrex(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
Devices Interventional Cardiology Neurology Personnel

HSMN NewsFeed - 30 Jan 2009
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jan 2009
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2008
TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2008
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2008
Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
Devices Cardiology Litigation

HSMN NewsFeed - 28 Oct 2008
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Sep 2008
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2008
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals

HSMN NewsFeed - 4 Aug 2008
Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Jul 2008
Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 24 Jul 2008
NuPathe Inc. Completes $30 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Jul 2008
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2008
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Jun 2008
New Technology Provides Drug-Free Approach to Treat Migraine
Devices Neurology

HSMN NewsFeed - 26 Jun 2008
Medtronic Announces First Clinical Data on Occipital Nerve Stimulation for Chronic Migraine to Be Presented at American Headache Society Meeting
Devices Neurology

HSMN NewsFeed - 16 Jun 2008
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals

HSMN NewsFeed - 20 May 2008
NovaDel Announces European License Agreement for Ondansetron Oral Spray
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2008
NMT Medical Announces Settlement of Damages Claims in Patent Infringement Lawsuit with Cardia
Devices Litigation

HSMN NewsFeed - 9 May 2008
St. Jude Medical to Launch New Brand Identity
Devices Cardiology

HSMN NewsFeed - 7 May 2008
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
Biopharmaceuticals

HSMN NewsFeed - 7 May 2008
Spectrum Pharmaceuticals Receives $20 Million Cash Payment from Par Pharmaceutical for Sumatriptan Injection
Biopharmaceuticals

HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2008
Addex Appoints Laurent Massuyeau as Head of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2008
Zogenix Completes Management Team with Cynthia Robinson, Ph.D., CDO, & Mark Thompson, VP, Sales & Managed Markets
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 17 Apr 2008
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Apr 2008
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2008
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro(TM) to Desitin Pharmaceuticals, GmbH
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 28 Feb 2008
XenoPort and GlaxoSmithKline Report Positive Top-Line Results of Final Pivotal Trial of XP13512/GSK1838262 for Restless Legs Syndrome
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2008
MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2008
Aporo Biomedical Announces Global Licensing Agreement for Proprietary Polymers Used to Treat Structural Heart Disease
Devices Interventional Cardiology Licensing

HSMN NewsFeed - 30 Jan 2008
NMT Medical Announces Separation of Chairman and Chief Executive Officer Roles
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 23 Jan 2008
NMT Medical Announces Significant Changes to Its Clinical Trial Plans in the United States
Devices Interventional Cardiology

HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2008
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jan 2008
NuPathe Names George Moonsammy, Ph.D. as Vice President of Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Nov 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Nov 2007
Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Nov 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation

HSMN NewsFeed - 1 Nov 2007
Stephen J. Peroutka, M.D., Ph.D. Joins Zogenix as Chief Medical Officer
Biopharmaceuticals Neurology Drug Delivery Personnel

HSMN NewsFeed - 1 Nov 2007
Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2007
Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Oct 2007
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2007
NMT Medical Appoints James J. Mahoney, Jr., to Board of Directors
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2007
POZEN Submits Response to Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2007
MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
Biopharmaceuticals

HSMN NewsFeed - 3 Oct 2007
Coherex Medical Successfully Completes First Human Cases with Its Coherex FlatStent PFO Closure System as Company Begins COHEREX-EU Study to Seek CE Mark Clearance
Devices Interventional Cardiology

HSMN NewsFeed - 2 Oct 2007
Coherex Medical to Begin its COHEREX-EU Study to Pursue CE Mark Clearance for its Coherex FlatStent PFO Closure System
Devices Interventional Cardiology

HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2007
Top PFO Specialists Perform First Human Placement of Sutura's SuperStitch EL To Close a Patent Foramen Ovale
Devices Cardiology

HSMN NewsFeed - 21 Aug 2007
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Biopharmaceuticals

HSMN NewsFeed - 20 Aug 2007
NeurAxon Announces $32 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Aug 2007
Noven Completes Acquisition of JDS Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Aug 2007
Actavis Receives Approval for Generic Inderal LA Capsules in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Appoints Shashidhar Kori New Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2007
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2007
TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Biopharmaceuticals

HSMN NewsFeed - 2 Aug 2007
FDA Issues Second Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 26 Jul 2007
MAP Pharmaceuticals Appoints General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2007
NMT Medical Announces the Commercial Launch of BioSTAR(R) in Europe and Canada
Devices Interventional Cardiology

HSMN NewsFeed - 25 Jul 2007
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine

HSMN NewsFeed - 13 Jul 2007
NMT Medical Appoints David L. West, Ph.D., MPH to Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 12 Jul 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
Biopharmaceuticals

HSMN NewsFeed - 11 Jul 2007
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Jul 2007
Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2007
Women's Menstrual Cycles Can Be Seasonal with SEASONALE(TM): First Extended-Cycle Oral Contraceptive Approved by Health Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Jun 2007
NMT Medical Receives CE Mark Approval for BioSTAR(R)
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 26 Jun 2007
MAP Pharmaceuticals Appoints Bernard J. Kelley to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Jun 2007
Cardica and Cook Medical Enter New Collaboration Agreement to Develop and Commercialize Closure Device for Heart Defects
Devices Cardiology

HSMN NewsFeed - 18 Jun 2007
NMT Medical's BioSTAR(R) Receives Canadian Regulatory Approval
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 13 Jun 2007
Bradley Pharmaceuticals Announces Launch of Elestrin(TM)
Biopharmaceuticals

HSMN NewsFeed - 8 Jun 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2007
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2007
NMT Medical Wins Favorable Ruling in Patent Infringement Lawsuit Against Cardia
Devices Interventional Cardiology Litigation

HSMN NewsFeed - 31 May 2007
Cobalis Announces Delay in Reporting of Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
Biopharmaceuticals

HSMN NewsFeed - 21 May 2007
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 7 May 2007
ProEthic Names James R. Lattanzi Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2007
Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Biopharmaceuticals

HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Apr 2007
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Apr 2007
NMT Medical Receives FDA Approval for Modifications in Pivotal U.S. PFO/Stroke Trial
Devices FDA Interventional Cardiology Neurology

HSMN NewsFeed - 18 Apr 2007
Coherex Medical, Inc. Announces Closing of $8.525 Million Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 29 Mar 2007
Cobalis Locks Database for Pivotal Twin Phase III Trials of PreHistin(TM) in Seasonal Allergic Rhinitis
Biopharmaceuticals

HSMN NewsFeed - 27 Mar 2007
MAP Pharmaceuticals Closes $50 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Mar 2007
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
Biopharmaceuticals

HSMN NewsFeed - 22 Mar 2007
Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin(TM) in April 2007
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Mar 2007
Anthony Tebbutt Joins Alexza Pharmaceuticals as Senior Vice President, Corporate Strategy & Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Mar 2007
Cortex Pharmaceuticals Appoints Les Street, Ph.D., Head of Medicinal Chemistry and Steven A. Johnson, Ph.D., VP of Pre-Clinical Development Becomes an Officer of Cortex
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2007
Cobalis' Mexican Patent for PreHistin(TM) Allowed
Biopharmaceuticals

HSMN NewsFeed - 26 Feb 2007
FDA Approves Cymbalta(R) for Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel

HSMN NewsFeed - 20 Feb 2007
Cobalis Appoints Three Pharmaceutical Industry Executives to Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2007
Par Pharmaceutical Receives Approval of Generic Inderal-LA(R)
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 10 Jan 2007
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2007
Capnia Announces Appointment of Joseph J. Vallner as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Dec 2006
Pozen Expects to Submit Revised Response to Trexima(TM) (Sumatriptan/Naproxen Sodium) Approvable Letter by Year End
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2006
Endo Pharmaceuticals Appoints Charles Rowland as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2006
Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Nov 2006
Cobalt Announces Settlement of Imitrex(R) Litigation With GlaxoSmithKline
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Nov 2006
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Nov 2006
Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 9 Nov 2006
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2006
Joseph Baker Joins Alexza Pharmaceuticals as Vice President, Commercial Manufacturing & Global Supply Chain
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology

HSMN NewsFeed - 25 Oct 2006
CoLucid Names James F. White as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Oct 2006
U.S. District Court Grants Request for Preliminary Injunction to Ortho-McNeil Neurologics, Inc. for TOPAMAX(R)
Biopharmaceuticals Neurology Generics Litigation

HSMN NewsFeed - 24 Oct 2006
NMT Medical's BioSTAR(R) Data Presented at 2006 TCT Scientific Symposium
Devices Interventional Cardiology

HSMN NewsFeed - 17 Oct 2006
Paul Strauss, M.D. Joins Omeros as VP, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2006
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2006
MAP Pharmaceuticals Appoints New Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2006
MAP Pharmaceuticals Appoints New Sr. Vice President of Corporate and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Oct 2006
Dr. Reddy's Announces Settlement of Imitrex(R) Litigation with GlaxoSmithKline
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 4 Oct 2006
NMT Medical's BioSTAR(R) Data to be Presented at the 2006 TCT Scientific Symposium
Devices Interventional Cardiology

HSMN NewsFeed - 4 Oct 2006
TorreyPines Therapeutics Completes Merger With Axonyx
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
Axonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
NovaDel Announces Positive Results from Pharmacokinetic Study of Improved Sumatriptan Oral Spray Formulation
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Sep 2006
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Sep 2006
New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Have Higher Sustained Pain-Free Rates Than Those Who Treat Late
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
New Data Show Consistent Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Across Multiple Migraine Attacks
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
New Data Show Peak Concentration of Sumatriptan Occurred Earlier With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Compared to Imitrex(R) (Sumatriptan Succinate)
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2006
NMT Medical Appeals Court's Ruling in Patent Infringement Lawsuit Against Cardia
Devices Litigation

HSMN NewsFeed - 13 Sep 2006
NuPathe Closes $15 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals

HSMN NewsFeed - 19 Jul 2006
Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Menstrual Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jul 2006
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jul 2006
MAP Pharmaceuticals Appoints New Program Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2006
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 24 May 2006
Mylan Announces Tentative Approval for Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 22 May 2006
ProEthic Pharmaceuticals Initiates Pivotal Phase III Trial for Fast-Acting Migraine Product Candidate
Biopharmaceuticals

HSMN NewsFeed - 19 May 2006
Cyberonics Provides Update on Annual American Psychiatric Association Meeting Activities and Recent VNS Therapy Publications
Devices Neurology

HSMN NewsFeed - 17 May 2006
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Cyberonics Announces Patient Enrollment in New TRD Dosing Study
Devices Neurology

HSMN NewsFeed - 16 May 2006
Clinical Trial Data from NMT Medical's BEST Trial Presented at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 11 May 2006
Dr. Gerald J. Yakatan Appointed CEO of Cobalis Corp.
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Biopharmaceuticals

Return to NewsFeed

Additional items found! 234

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 234 additional stories matching:
Migraine
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.